Citation sources

Updated weekly. Details via Crossref

Crossref	Scopus	Google Scholar
6	6	Search

2025	Mechanistic Insights and Clinical Implications of ELK1 in Solid Tumors: A Narrative Review Cells Georgios Kalampounias, Theodosia Androutsopoulou, Panagiotis Katsoris
2024	Pan-cancer multi-omics analysis of PTBP1 reveals it as an inflammatory, progressive and prognostic marker in glioma Scientific Reports Zheng Ye, Yan Zhong, Zhiyuan Zhang
2022	Degradation of STK16 via KCTD17 with Ubiquitin–Proteasome System in Relation to Sleep–Wake Cycle Kinases and Phosphatases Susumu Tanaka, Yoshiko Honda, Misa Sawachika, Kensuke Futani, Namika Yoshida, Tohru Kodama
2021	Prediction of ATPase cation transporting 13A2 molecule in Petromyzon marinus and pan-cancer analysis into human tumors from an evolutionary perspective Immunogenetics Kaifeng Zheng, Tiesong Li
2020	The STK16 inhibitor STK16-IN-1 inhibits non-adrenergic and non-neurogenic smooth muscle contractions in the human prostate and the human male detrusor Naunyn-Schmiedeberg's Archives of Pharmacology Bingsheng Li, Xiaolong Wang, Beata Rutz, Ruixiao Wang, Alexander Tamalunas, Frank Strittmatter, Raphaela Waidelich, Christian G. Stief, Martin Hennenberg
2020	PSMB8-AS1 activated by ELK1 promotes cell proliferation in glioma via regulating miR-574-5p/RAB10 Biomedicine & Pharmacotherapy Gang Shen, Yuhang Mao, Zuopeng Su, Jiarui Du, Yong Yu, Fulin Xu
2019	Serine/Threonine Protein Kinase STK16 International Journal of Molecular Sciences Junjun Wang, Xinmiao Ji, Juanjuan Liu, Xin Zhang
	Additional cited-by details will be shown when available from Crossref